QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-O13/LOGiC Trial of Lapatinib 期刊论文 2017, 卷号: 16, 期号: 1, 页码: 228-238 作者:  Press, Michael F.;  Ellis, Catherine E.;  Gagnon, Robert C.;  Grob, Tobias J.;  Buyse, Marc 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC-A Randomized Phase III Trial 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2016, 卷号: 34, 期号: 5 作者:  Hecht, J. Randolph;  Bang, Yung-Jue;  Qin, Shukui K.;  Chung, Hyun C.;  Xu, Jianming M. 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/06 Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+advanced breast cancer: BOLERO-1 会议论文 作者:  Hurvitz, Sara A.;  Andre, Fabrice;  Jiang, Zefei;  Shao, Zhimin;  Neciosup, Silvia P. 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/19 Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial 期刊论文 LANCET ONCOLOGY, 2015, 卷号: 16, 期号: 7 作者:  Hurvitz, Sara A.;  Andre, Fabrice;  Jiang, Zefei;  Shao, Zhimin;  Mano, Max S. 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19 Post-hoc analyses of overall survival (OS) and progression-free survival (PFS) in the TRIO-013/LOGiC trial of lapatinib (L) in combination with capecitabine plus oxaliplatin (CapeOx) 会议论文 作者:  Bang, Yung-Jue;  Qin, Shukui;  Chung, Hyun-Choel;  Xu, Jian-Ming;  Park, Joon Oh 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/19 Lapatinib in combination with capecitabine plus oxaliplatin (CapeOx) in HER2 positive advanced or metastatic gastric (A/MGC), esophageal (EAC), or gastroesophageal (GEJ) adenocarcinoma: The LOGiC trial. 会议论文 作者:  Hecht, J. Randolph;  Bang, Yung-Jue;  Qin, Shukui;  Chung, Hyun-Chul;  Xu, Jian-Ming 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/19 Lapatinib in combination with capecitabine plus oxaliplatin (CapeOx) in HER2-positive advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma (AC): The TRIO-013/LOGiC Trial. 会议论文 作者:  Hecht, J. Randolph;  Bang, Yung-Jue;  Qin, Shukui;  Chung, Hyun-Chul;  Xu, Jian-Ming 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19